Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical tria…

Biotechnology

US, Bala Cynwyd [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Larimar Therapeutics, Inc. to fulfill lobbying activities in the US.

Larimar Therapeutics, Inc. has no lobbying expenses in our database.

History

Download

FY	Quarter	Expense For Lobby Disclosure	LDA Reference
No data